We are monitoring the impact of COVID-19 & Recession alarm on APAC Non-Invasive Prenatal Testing Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Non-Invasive Prenatal Testing Market Research Report - Segmented By Instruments, Method, Application, End User, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2703
Pages: 140

APAC Non-Invasive Prenatal Testing Market Size (2022 to 2027)

The size of the Non-Invasive Prenatal Testing Market was valued at USD 0.47 Billion in 2022. It is further projected to be growing at a CAGR of 20.3% and worth USD 1.18 billion by 2027.

The high incidence of chromosomal abnormalities with increasing maternal age, a growing preference for non-invasive treatments over invasive methods, and a better reimbursement situation for NIPT are primarily driving the market's growth in the APAC region. In the future, emerging markets such as China India are likely to provide considerable growth possibilities for market competitors. The improved healthcare infrastructure, increasing public healthcare expenditure, the presence of a big target patient population, and expanding awareness and availability of modern technology contribute to these markets' rapid rise.

The rise in the incidence of chronic diseases such as cancer and diabetes has increased the patient pool, which has increased demand for biological medications to treat various chronic diseases, fueling the growth of the Non-Invasive Prenatal Testing market. In addition, changing lifestyles, dietary habits, and exposure to mutagenic chemicals threaten to produce spontaneous mutations in fetuses and expectant mothers, leading to an increase in genetic and congenital disorders. This factor is expected to fuel demand for the Asia Pacific non-invasive prenatal diagnostics market during the forecast period.

One of the market's main driving forces is the improvement of payment policies for ordinary and low-risk pregnancies. Furthermore, non-invasive prenatal tests' advantages over other prenatal tests, such as their non-invasive nature, higher accuracy, and shorter procedure time, are expected to propel the NIPT market forward during the forecast period. Several public health authorities in significant nations have begun to offer these tests directly or are planning to do so soon. As the population becomes more aware of these procedures, the adoption and revenue growth of the test market is predicted to accelerate.

However, lack of test accessibility, ethical issues, and rigorous government regulations are only a few factors that will limit the Non-Invasive Prenatal Testing market's growth. At the same time, decreased per capita healthcare spending and a lack of suitable test reimbursement policies are two other factors that could hamper the APAC non-invasive prenatal testing market's growth.

This research report on the Asia Pacific non-invasive prenatal testing market has been segmented and sub-segmented into the following categories.

By Instruments: 

  • Ultrasound
  • NGS
  • PCR
  • Microarray

By Method: 

  • FCMB
  • Cf-DNA

By Application: 

  • Trisomy
  • Microdeletion
  • Genetics
  • Rh Factor

By End User: 

  • Hospitals
  • Diagnostic Labs

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

The Asia Pacific is expected to be the fastest-growing regional market throughout the forecast period. The presence of companies like BGI, a significant player in the Non-Invasive Prenatal Testing market (NIPT) market in China, is expected to move the market ahead. Growing healthcare infrastructure, more awareness programs and conferences, and major companies' more significant focus on expanding their presence in Asia are all driving market growth in Asia. In the future, the market will have a lot of space to grow. The high adoption rate of non-invasive prenatal testing in the APAC region, particularly in China, Australia, and New Zealand, is a prominent factor driving market expansion. In China, young maternal age and high-risk pregnancies are expected to be three times greater than in the United States, indicating a profitable market for non-invasive prenatal diagnostics in the Asia Pacific region.

KEY MARKET PLAYERS:

Companies playing a key role in the Asia Pacific non-invasive prenatal testing market profiled in this report are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Instruments                               

                                5.1.1 Introduction           

                                5.1.2 PCR            

                                5.1.3 Ultrasound              

                                5.1.4 NGS           

                                5.1.5 Microarray              

                                5.1.6  Y-o-Y Growth Analysis, By Instruments     

                                5.1.7  Market Attractiveness Analysis, By Instruments   

                                5.1.8  Market Share Analysis, By Instruments     

                5.2 Method                       

                                5.2.1 Introduction           

                                5.2.2 FCMB        

                                5.2.3 Cell-Free DNA (cf-DNA)     

                                5.2.4 Y-o-Y Growth Analysis, By Method               

                                5.2.5 Market Attractiveness Analysis, By Method             

                                5.2.6 Market Share Analysis, By Method              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Trisomy    

                                5.3.3 Microdeletion        

                                5.3.4 Genetics  

                                5.3.5 Rh factor  

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7  Market Attractiveness Analysis, By Application      

                                5.3.8  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospital    

                                5.4.3 Diagnostic Labs      

                                5.4.4 Y-o-Y Growth Analysis, By End User             

                                5.4.5  Market Attractiveness Analysis, By End User          

                                5.4.6  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Instruments

                                                6.1.3.3 By Method

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Instruments

                                                6.1.4.3 By Method

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Instruments

                                                6.1.5.3 By Method

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 GE Healthcare                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Koninklijke Philips N.V                           

                8.3 Thermo Fisher Scientific                        

                8.4 Hoffman-La Roche                  

                8.5 Pacific Biosciences of California                          

                8.6 PerkinElmer                               

                8.7 QIAGEN N.V                               

                8.8 Agilent Technologies                              

                8.9 Beijing Genomics Institute                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Asia-Pacific Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Ultrasound Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia-Pacific NGS Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific PCR Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Microarray Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  7. Asia-Pacific FCMB Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia-Pacific cf-DNA Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  10. Asia-Pacific Trisomy Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific Microdeletion Market, By Region, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Genetics Market, By Region, From 2022 - 2027 (USD Million)
  13. Asia-Pacific Rh Factor Market, By Region, From 2022 - 2027 (USD Million)
  14. Asia-Pacific Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)
  15. Asia-Pacific Hospital Market, By Region, From 2022 - 2027 (USD Million)
  16. Asia-Pacific Diagnostic Labs Market, By Region, From 2022 - 2027 (USD Million)
  17. Japan Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  18. Japan Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  19. Japan Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  20. Japan Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)
  21. China Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  22. China Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  23. China Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  24. China Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)
  25. India Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  26. India Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  27. India Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  28. India Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)
  29. Australia Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  30. Australia Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  31. Australia Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  32. Australia Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)
  33. South Korea Non-Invasive Prenatal Testing Market, By Instruments, From 2022 - 2027 (USD Million)
  34. South Korea Non-Invasive Prenatal Testing Market, By Method, From 2022 - 2027 (USD Million)
  35. South Korea Non-Invasive Prenatal Testing Market, By Application, From 2022 - 2027 (USD Million)
  36. South Korea Non-Invasive Prenatal Testing Market, By End User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample